MSB 0.51% 97.0¢ mesoblast limited

Heart Failure Readout - Just around the corner

  1. 4,180 Posts.
    lightbulb Created with Sketch. 5443
    This is posted elsewhere, but it is worth considering on the eve of a Yes/No FDA APPROVAL for Ryoncil if you are wondering what plan B, C and D are. Importantly, Plan B/C/D are all substantially more financially significant for the company than Ryoncil approval for Pediatric SRaGVHD is.

    The first 50 minutes explains the progress that has been made over the last 20 years in the treatment of heart failure, with various stem cell products including some from Mesoblast and culminates in the Doc talking about the Mesoblast phase 3 trial and how it is a trial for product approval to the FDA.

    He talks about the data unblinding due in May 2020, and that if there were very positive results, the results would be published around August September 20. ( this was pre-covid )

    He also says if it's not very positive that the results would come out in at the American heart association meeting - which is scheduled to be an online event November 13-17 2020.

    What can we take out of this? The phase 3 reveal should occur prior to or during the Nov 13 -17th date. ie...... within about 50 days.

    American Heart Association Meeting:
    https://exhibitatsessions.org/scientific-sessions/


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.005(0.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.5¢ 98.5¢ 96.0¢ $2.168M 2.226M

Buyers (Bids)

No. Vol. Price($)
1 16000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 86854 7
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.